We read with interest the paper by Magini and colleagues on the measurement of pulmonary diffusing capacity for nitric oxide in patients with heart failure (ejection fraction<40%). 1 In their study they report pulmonary diffusing capacity and the individual components of pulmonary diffusing capacity in 50 patients with heart failure (65 years of age), and 50 control subjects (61 years of age). We feel that there are two problems with this paper that warrant discussion. First, the mean values for pulmonary diffusing capacity for nitric oxide (DL NO ) for the healthy subjects are too low, and second, both their alveolar-membrane conductances (Dm NO and Dm CO ) and pulmonary capillary blood volume (Vc) calculations, and hence conclusions, are incorrect.
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First, the values for DL NO for the healthy volunteers appear too low. If we assume that the women's and men's mean height in the healthy volunteers was 163 and 173 cm, respectively, then the mean DLNO values should be 96-113 and 140-154 ml/min/mm Hg, for women and men, respectively. 2, 3 The combined average for DL NO should be then 118-133 ml/min/mm Hg. The author's mean values of 89 ml/min/mm Hg for the healthy volunteers are 25-33% lower than predicted. However, their values for pulmonary diffusing capacity for carbon monoxide (DL CO ) were correct and the healthy volunteers was close to 100% of that predicted. 2, 3 Thus, if the mean DL NO in the control group is under-predicted by at least 25%, then the DL NO values in the heart failure patients could be under predicted by !25% too. Since DL NO and DL CO are measured simultaneously, and DL CO values were appropriate (close to 100% of those predicted), there must be some mathematical error in the calculation of DL NO and/or their breath-hold time was too short. The breath-hold time should be 5-10 s, 4 and it seems that their breath-hold time varied between 2-4 s.
Second, in the discussion they state ''Vcap was unchanged, and the DL NO /DL CO ratio was 4.1 in healthy subjects and 4.4 in heart failure patients.'' Hughes and Van der Lee 5 have elegantly illustrated how DL NO /DL CO is a proxy for Dm/Vc so the only way for the patients in this study to have an unchanged Vc and a raised DL NO /DL CO is for them to have a higher Dm than the normal controls! Clearly Magini et al.'s calculations of Vc (and Dm) are wrong. They have used the 1957 value for y CO ; Forster states that his 1957 value is incorrect and that the 1987 value should be used instead. 6 Magini et al. have assumed that DL NO ¼ Dm NO i.e. that y NO is infinity, a view originally asserted by the Bordeaux group. 7 Nitric oxide transfer is now known to increase with hemolysis in vitro 8 and with addition of a cell-free blood substitute in vitro and in vivo 9 indicating that y NO is finite and that DL NO < Dm NO . We and the Bordeaux group 10 recommend using the values for y NO and y CO derived from rate constants measured using the Continuous Flow Rapid Reaction apparatus at the University of Pennsylvania. 11 We have recalculated Magini et al.'s data using these values and present them below in Table 1 .
We can see that the DL NO /DL CO ratio and Dm/Vc ratio are both increased in the patients. We also see that the reduction in gas transfer in the patients is predominantly due to reduction in Vc rather than Dm.This is contrary to what others have found using the conventional Roughton-Forster approach at two or more oxygen tensions. 12 However cardiac failure is a complex pathophysiological state and it is likely that there are differences in lung function between patients and within patients at differing stages of their disease and varying with treatment. 
